52 North is developing the world’s first finger-prick blood test to provide both a white blood cell count and blood lactate level, enabling rapid triage of chemotherapy patients at risk of life-threatening infections. 52 North is a spin-out from the University of Cambridge.
Location: United Kingdom, England, Cambridge
Total raised: $7.3M
Investors 2
| Date | Name | Website |
| 20.05.2022 | Cambridge ... | cambridgea... |
| 02.05.2022 | Parkwalk A... | parkwalkad... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 11.12.2024 | - | $6.02M | - |
| 03.05.2022 | Seed | $1.27M | - |
Mentions in press and media 13
| Date | Title | Description |
| 05.09.2025 | 15 Companies Advance to NATO DIANA 2025 Phase 2, Two Focused on 3D Printing | NATO’s Defence Innovation Accelerator for the North Atlantic (DIANA) has revealed the 15 companies from 10 NATO countries advancing to Phase 2 of its 2025 cohort. The selection showcases solutions in defence and dual-use technologies, spann... |
| 11.12.2024 | 52North secures $6M with landmark UK-US hospital VC deal | 52North secures $6M in ground-breaking fundraise, first to be co-led by a UK-US hospital venture capital partnership. 52North, the med-tech company focused on transforming urgent care pathways in oncology, has announced the close of a major... |
| 07.12.2024 | 52North: Pioneering the Future of Oncology Care with New Funding | In the heart of Cambridge, a med-tech startup is stirring the pot of oncology care. 52North has secured a substantial £4.72 million in funding, a lifeline that promises to propel its innovative solutions into the market. This funding round,... |
| 06.12.2024 | 52North Raises £4.72M in Funding | 52North, a Cambridge, UK-based med-tech company focused on urgent care pathways in oncology, raised £4.72M in funding. The round was led by KHP Ventures, and Cedars-Sinai Intellectual Property Co., with participation from OKG Capital, Cambr... |
| 03.12.2024 | Cambridge-based 52North secures €5.7 million funding to advance oncology-focused innovations | 52North, a UK med-tech startup focused on oncological advancements, has raised €6 million in a funding round co-led by KHP Ventures and Cedars-Sinai Intellectual Property Co. (CSIP). The round, which also included contributions from OKG Cap... |
| 30.04.2022 | Med-tech Platform 52 North Health raises GBP 1 Million in First Round of Funding | U.S. and U.K-based med-tech startup 52 North Health raises GBP 1 million in the first round of funding. The round took place on April 28, 2022. Cambridge Enterprise, the commercialisation arm of the University of Cambridge, led the round fo... |
| 29.04.2022 | 52 North Health gets £1 million shot to boost affordable cancer care | The advent of personalised medicine and an increasingly decentralised healthcare system – a need accelerated by the pandemic – has led to the rise of many health tech startups focusing on the segment. Joining the bandwagon of companies look... |
| 29.04.2022 | 52 North Health gets £1 million shot to boost affordable cancer care | - |
| 29.04.2022 | Medtech startup 52 North Health raises £1m to trial sepsis testing device | Medtech startup 52 North Health has raised £1m in its first funding round, led by Cambridge Enterprise. Cambridge-headquartered 52 North will use the capital to fund clinical trials for its NeutroCheck device. It also plans to pursue partne... |
| 29.04.2022 | VCs see promise in the religious metaverse—and a market of 6 billion people | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Hi Term Sheet readers! Jackson Fordyce here filling in for Jessica. Paid Content How Northrop Gru... |
Show more